Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Design considerations for future radionuclide aerosol monitoring systems.

Miley HS, Burnett JL, Chepko AB, Devoy CL, Eslinger PW, Forrester JB, Friese JI, Lidey LS, Morris SJ, Schrom BT, Stokes S, Swanwick ME, Smart JE, Warren GA.

J Environ Radioact. 2019 Aug 30;208-209:106037. doi: 10.1016/j.jenvrad.2019.106037. [Epub ahead of print]

2.

PRex: An Experiment to Investigate Detection of Near-field Particulate Deposition from a Simulated Underground Nuclear Weapons Test Vent.

Keillor ME, Arrigo LM, Baciak JE, Chipman V, Detwiler RS, Emer DF, Kernan WJ, Kirkham RR, MacDougall MR, Milbrath BD, Rishel JP, Seifert A, Seifert CE, Smart JE.

Health Phys. 2016 May;110(5):533-47. doi: 10.1097/HP.0000000000000506.

PMID:
27023040
3.

Using Atmospheric Dispersion Theory to Inform the Design of a Short-lived Radioactive Particle Release Experiment.

Rishel JP, Keillor ME, Arrigo LM, Baciak JE, Detwiler RS, Kernan WJ, Kirkham RR, Milbrath BD, Seifert A, Seifert CE, Smart JE.

Health Phys. 2016 May;110(5):526-32. doi: 10.1097/HP.0000000000000475.

PMID:
27023039
4.

An evaluation of the adhesion of solid oral dosage form coatings to the oesophagus.

Smart JD, Dunkley S, Tsibouklis J, Young S.

Int J Pharm. 2015 Dec 30;496(2):299-303. doi: 10.1016/j.ijpharm.2015.10.014. Epub 2015 Oct 21.

PMID:
26453786
5.

Delivery of treatment for hepatitis C virus infection in the primary care setting.

Baker D, Alavi M, Erratt A, Hill S, Balcomb A, Hallinan R, Siriragavan S, Richmond D, Smart J, Keats J, Doong N, Marks P, Grebely J, Dore GJ.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1003-9. doi: 10.1097/MEG.0000000000000150.

PMID:
25051216
6.

An in vitro model for the evaluation of the adhesion of solid oral dosage forms to the oesophagus.

Smart JD, Dunkley S, Tsibouklis J, Young S.

Int J Pharm. 2013 Apr 15;447(1-2):199-203. doi: 10.1016/j.ijpharm.2013.02.017. Epub 2013 Mar 1.

PMID:
23467079
7.

Nasal and buccal drug delivery: management forum conference.

Smart JD.

Ther Deliv. 2012 Jul;3(7):819-22.

PMID:
22900464
8.

Chitosan microparticles for the controlled delivery of fluoride.

Keegan GM, Smart JD, Ingram MJ, Barnes LM, Burnett GR, Rees GD.

J Dent. 2012 Mar;40(3):229-40. doi: 10.1016/j.jdent.2011.12.012. Epub 2011 Dec 23.

PMID:
22212236
9.

Metabolism of captopril carboxyl ester derivatives for percutaneous absorption.

Gullick DR, Ingram MJ, Pugh WJ, Cox PA, Gard P, Smart JD, Moss GP.

J Pharm Pharmacol. 2009 Feb;61(2):159-65. doi: 10.1211/jpp/61.02.0004.

PMID:
19178762
10.

Clinical relevance of dissolution testing in quality by design.

Dickinson PA, Lee WW, Stott PW, Townsend AI, Smart JP, Ghahramani P, Hammett T, Billett L, Behn S, Gibb RC, Abrahamsson B.

AAPS J. 2008 Jun;10(2):380-90. doi: 10.1208/s12248-008-9034-7. Epub 2008 Aug 7. Review.

11.

Azo compounds in colon-specific drug delivery.

Roldo M, Barbu E, Brown JF, Laight DW, Smart JD, Tsibouklis J.

Expert Opin Drug Deliv. 2007 Sep;4(5):547-60. Review.

PMID:
17880276
12.

An in vitro assessment of bioadhesive zinc/carbomer complexes for antimicrobial therapy within the oral cavity.

Keegan G, Smart J, Ingram M, Barnes L, Rees G, Burnett G.

Int J Pharm. 2007 Aug 1;340(1-2):92-6. Epub 2007 Mar 24.

PMID:
17452085
13.

Orally administered, colon-specific mucoadhesive azopolymer particles for the treatment of inflammatory bowel disease: An in vivo study.

Roldo M, Barbu E, Brown JF, Laight DW, Smart JD, Tsibouklis J.

J Biomed Mater Res A. 2006 Dec 1;79(3):706-15.

PMID:
16871516
14.

Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.

Moss GP, Gullick DR, Cox PA, Alexander C, Ingram MJ, Smart JD, Pugh WJ.

J Pharm Pharmacol. 2006 Feb;58(2):167-77.

PMID:
16451744
15.

Buccal drug delivery.

Smart JD.

Expert Opin Drug Deliv. 2005 May;2(3):507-17. Review.

PMID:
16296771
16.

The basics and underlying mechanisms of mucoadhesion.

Smart JD.

Adv Drug Deliv Rev. 2005 Nov 3;57(11):1556-68. Epub 2005 Sep 29. Review.

PMID:
16198441
17.

Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity.

Smart JD.

Crit Rev Ther Drug Carrier Syst. 2004;21(4):319-44. Review.

PMID:
15638469
18.

Mucoadhesive, triclosan-loaded polymer microspheres for application to the oral cavity: preparation and controlled release characteristics.

Kockisch S, Rees GD, Tsibouklis J, Smart JD.

Eur J Pharm Biopharm. 2005 Jan;59(1):207-16.

PMID:
15567319
19.

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A.

Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14907-12. Epub 2004 Sep 29.

20.

In situ evaluation of drug-loaded microspheres on a mucosal surface under dynamic test conditions.

Kockisch S, Rees GD, Young SA, Tsibouklis J, Smart JD.

Int J Pharm. 2004 May 19;276(1-2):51-8.

PMID:
15113613

Supplemental Content

Loading ...
Support Center